Skip to main content
Top
Published in: BMC Cancer 1/2020

01-12-2020 | Computed Tomography | Case report

Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature

Authors: Mingaile Drevinskaite, Ausvydas Patasius, Lukas Kevlicius, Ugnius Mickys, Giedre Smailyte

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

Malignant mesothelioma of the tunica vaginalis is a rare tumour which comprises less than 1% of all mesotheliomas.

Case presentation

69-years old patient with painful hard mass and hydrocele in the right scrotum to whom a right hydrocelectomy was performed. Any history of scrotal trauma or exposure to asbestos was not present. Excisional biopsy revealed a multinodular tumour with focal areas of necrosis and infiltrative growth. According to morphological and immunohistochemical findings, diagnosis of malignant biphasic mesothelioma of the tunica vaginalis testis was made. Two months after hydrocelectomy, right inguinal orchidectomy was performed. Post-surgical whole body CT scan revealed paraaortic and pararenal lymphadenopathy, likely to be metastatic. Adjuvant treatment with 6 cycles of cisplatin and pemetrexed was applied. After 3 cycles of chemotherapy, CT scan showed progression and the treatment was changed to gemcitabine 1 month after.

Conclusions

Although malignant mesothelioma of the tunica vaginalis is a rare malignancy, it poses a diagnostic challenge which can mimic common inguinal or scrotal diseases such as hydrocele. Despite aggressive surgical procedures or adjuvant therapies, the prognosis remains poor.
Literature
1.
go back to reference Mezei G, Chang ET, Mowat FS, Moolgavkar SH. Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol. 2017;27(5):348–359.e11.CrossRef Mezei G, Chang ET, Mowat FS, Moolgavkar SH. Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol. 2017;27(5):348–359.e11.CrossRef
2.
go back to reference Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, et al. Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register. Occup Environ Med. 2010;67(11):760–5.CrossRef Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, et al. Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register. Occup Environ Med. 2010;67(11):760–5.CrossRef
3.
go back to reference Zhang N, Fu N, Peng S, Luo X. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Mol Clin Oncol. 2017;7(6):1053–6.PubMedPubMedCentral Zhang N, Fu N, Peng S, Luo X. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Mol Clin Oncol. 2017;7(6):1053–6.PubMedPubMedCentral
4.
go back to reference Chen J-L, Hsu Y-H. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Kaohsiung J Med Sci. 2009;25(2):77–81.CrossRef Chen J-L, Hsu Y-H. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Kaohsiung J Med Sci. 2009;25(2):77–81.CrossRef
5.
go back to reference Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol. 1995;19(7):815–25.CrossRef Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol. 1995;19(7):815–25.CrossRef
6.
go back to reference Brimo F, Illei PB, Epstein JI. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential. Mod Pathol Off J U S Can Acad Pathol Inc. 2010;23(8):1165–72. Brimo F, Illei PB, Epstein JI. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential. Mod Pathol Off J U S Can Acad Pathol Inc. 2010;23(8):1165–72.
7.
go back to reference Trenti E, Palermo SM, D’Elia C, Comploj E, Pycha A, Carella R, et al. Malignant mesothelioma of tunica vaginalis testis: report of a very rare case with review of the literature. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol. 2018;90(3):212–4.CrossRef Trenti E, Palermo SM, D’Elia C, Comploj E, Pycha A, Carella R, et al. Malignant mesothelioma of tunica vaginalis testis: report of a very rare case with review of the literature. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol. 2018;90(3):212–4.CrossRef
9.
go back to reference Bisceglia M, Dor DB, Carosi I, Vairo M, Pasquinelli G. Paratesticular mesothelioma. Report of a case with comprehensive review of literature. Adv Anat Pathol. 2010;17(1):53–70.CrossRef Bisceglia M, Dor DB, Carosi I, Vairo M, Pasquinelli G. Paratesticular mesothelioma. Report of a case with comprehensive review of literature. Adv Anat Pathol. 2010;17(1):53–70.CrossRef
10.
go back to reference Yen C-H, Lee C-T, Su C-J, Lo H-C. Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epididymitis? World J Surg Oncol. 2012;10:238.CrossRef Yen C-H, Lee C-T, Su C-J, Lo H-C. Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epididymitis? World J Surg Oncol. 2012;10:238.CrossRef
11.
go back to reference Mrinakova B, Ondrus D, Kajo K, Kunderlik M, Tkacova M, Ondrusova M. Paratesticular mesothelioma in young age. Case report. Klin Onkol Cas Ceske Slov Onkol Spolecnosti. 2012;25(4):290–3. Mrinakova B, Ondrus D, Kajo K, Kunderlik M, Tkacova M, Ondrusova M. Paratesticular mesothelioma in young age. Case report. Klin Onkol Cas Ceske Slov Onkol Spolecnosti. 2012;25(4):290–3.
12.
go back to reference Akin Y, Bassorgun I, Basara I, Yucel S. Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors. Singap Med J. 2015;56(3):e53–5.CrossRef Akin Y, Bassorgun I, Basara I, Yucel S. Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors. Singap Med J. 2015;56(3):e53–5.CrossRef
13.
go back to reference Maheshwari PN, Abiola OO, Wagaskar VG, Oswal AT. Hydrocele with a surprise: malignant mesothelioma of the tunica vaginalis - case report and review of literature. Urol Ann. 2017;9(1):110–2.CrossRef Maheshwari PN, Abiola OO, Wagaskar VG, Oswal AT. Hydrocele with a surprise: malignant mesothelioma of the tunica vaginalis - case report and review of literature. Urol Ann. 2017;9(1):110–2.CrossRef
14.
go back to reference Gürdal M, Erol A. Malignant mesothelioma of tunica vaginalis testis associated with long-lasting hydrocele: could hydrocele be an etiological factor? Int Urol Nephrol. 2001;32(4):687–9.CrossRef Gürdal M, Erol A. Malignant mesothelioma of tunica vaginalis testis associated with long-lasting hydrocele: could hydrocele be an etiological factor? Int Urol Nephrol. 2001;32(4):687–9.CrossRef
15.
go back to reference Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–7.CrossRef Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320(5876):674–7.CrossRef
16.
go back to reference Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-Asbestos causes. Arch Pathol Lab Med. 2018;142(6):753–60.CrossRef Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant mesothelioma and its non-Asbestos causes. Arch Pathol Lab Med. 2018;142(6):753–60.CrossRef
17.
go back to reference Humans IWG on the E of CR to. Radiation. International Agency for Research on Cancer; 2012. Humans IWG on the E of CR to. Radiation. International Agency for Research on Cancer; 2012.
18.
go back to reference Ferri E, Azzolini N, Sebastio N, Salsi P, Meli S, Cortellini P. Unusual case of mesothelioma of the tunica vaginalis associated with prostatic adenocarcinoma. Minerva Urol E Nefrol Ital J Urol Nephrol. 2000;52(1):33–5. Ferri E, Azzolini N, Sebastio N, Salsi P, Meli S, Cortellini P. Unusual case of mesothelioma of the tunica vaginalis associated with prostatic adenocarcinoma. Minerva Urol E Nefrol Ital J Urol Nephrol. 2000;52(1):33–5.
19.
go back to reference Plas E, Riedl CR, Pflüger H. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Cancer. 1998;83(12):2437–46.CrossRef Plas E, Riedl CR, Pflüger H. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Cancer. 1998;83(12):2437–46.CrossRef
20.
go back to reference Blaivas M, Brannam L. Testicular ultrasound. Emerg Med Clin North Am. 2004;22(3):723–48 ix.CrossRef Blaivas M, Brannam L. Testicular ultrasound. Emerg Med Clin North Am. 2004;22(3):723–48 ix.CrossRef
21.
go back to reference Bertolotto M, Boulay-Coletta I, Butini R, Dudea SM, Grenier N, Oltmanns G, et al. Imaging of mesothelioma of tunica vaginalis testis. Eur Radiol. 2016;26(3):631–8.CrossRef Bertolotto M, Boulay-Coletta I, Butini R, Dudea SM, Grenier N, Oltmanns G, et al. Imaging of mesothelioma of tunica vaginalis testis. Eur Radiol. 2016;26(3):631–8.CrossRef
22.
go back to reference Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol Off J U S Can Acad Pathol Inc. 2005;18(Suppl 2):S131–45. Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol Off J U S Can Acad Pathol Inc. 2005;18(Suppl 2):S131–45.
23.
go back to reference Nazemi A, Nassiri N, Pearce S, Daneshmand S. Testicular mesothelioma: an analysis of epidemiology, patient outcomes, and prognostic factors. Urology. 2019;126:140–4.CrossRef Nazemi A, Nassiri N, Pearce S, Daneshmand S. Testicular mesothelioma: an analysis of epidemiology, patient outcomes, and prognostic factors. Urology. 2019;126:140–4.CrossRef
24.
go back to reference Chekol SS, Sun C-C. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 2012;136(1):113–7.CrossRef Chekol SS, Sun C-C. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 2012;136(1):113–7.CrossRef
25.
go back to reference Allen TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med. 2005;129(11):1415–20.PubMed Allen TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med. 2005;129(11):1415–20.PubMed
26.
go back to reference Lloreta-Trull J. Extrathoracic mesothelial proliferations and their mimics. Ultrastruct Pathol. 2006;30(1):37–51.CrossRef Lloreta-Trull J. Extrathoracic mesothelial proliferations and their mimics. Ultrastruct Pathol. 2006;30(1):37–51.CrossRef
27.
go back to reference Ghosh P, Saha K. Primary adenocarcinoma of rete testis with distinct biphasic pattern: an extremely rare entity and diagnostic challenge. J Nat Sci Biol Med. 2015;6(1):211–3.CrossRef Ghosh P, Saha K. Primary adenocarcinoma of rete testis with distinct biphasic pattern: an extremely rare entity and diagnostic challenge. J Nat Sci Biol Med. 2015;6(1):211–3.CrossRef
28.
go back to reference Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol Off J Eur Soc Med Oncol. 2007;18(5):827–34.CrossRef Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol Off J Eur Soc Med Oncol. 2007;18(5):827–34.CrossRef
29.
go back to reference Recabal P, Rosenzweig B, Bazzi WM, Carver BS, Sheinfeld J. Malignant mesothelioma of the tunica Vaginalis testis: outcomes following surgical management beyond radical orchiectomy. Urology. 2017;107:166–70.CrossRef Recabal P, Rosenzweig B, Bazzi WM, Carver BS, Sheinfeld J. Malignant mesothelioma of the tunica Vaginalis testis: outcomes following surgical management beyond radical orchiectomy. Urology. 2017;107:166–70.CrossRef
30.
go back to reference Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(14):2636–44.CrossRef Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(14):2636–44.CrossRef
31.
go back to reference Favaretto AG, Aversa SML, Paccagnella A, Manzini VDP, Palmisano V, Oniga F, et al. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer. 2003;97(11):2791–7.CrossRef Favaretto AG, Aversa SML, Paccagnella A, Manzini VDP, Palmisano V, Oniga F, et al. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer. 2003;97(11):2791–7.CrossRef
Metadata
Title
Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature
Authors
Mingaile Drevinskaite
Ausvydas Patasius
Lukas Kevlicius
Ugnius Mickys
Giedre Smailyte
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-6648-3

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine